CIK 0001370053 · Non-accelerated filer<br>Smaller reporting company
ANAPTYSBIO, INC
Sign in to watch- Ticker
- ANAB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 203828755
- Phone
- 858-362-6295
- Business address
- 10770 WATERIDGE CIRCLE, SUITE 210, SAN DIEGO, CA, 92121
- Former names
- ANAPTYSBIO INC, ANAPTYS BIOSCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $249,372
- in 1 filing, $249K under 10b5-1 plans
Net −$249,372. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-07 | LOUMEAU ERIC J CHIEF LEGAL OFFICER | Sale | −500 | $47.23 | $24K | 9,157 |
| 2026-01-06 | Ware J. Anthony Director | Grant or award · Stock Option (right to buy) | +5,500 | 5,500 | ||
| 2026-01-06 | Ware J. Anthony Director | Grant or award · Restricted Stock Unit | +4,000 | 4,000 | ||
| 2026-01-06 | Lizzul Paul F. Chief Medical Officer | Option exercise | +6,145 | 39,448 | ||
| 2026-01-06 | Lizzul Paul F. Chief Medical Officer | Option exercise · Restricted Stock Unit | −6,145 | 6,145 | ||
| 2026-01-06 | Lizzul Paul F. Chief Medical Officer | Grant or award · Restricted Stock Unit | +21,400 | 21,400 | ||
| 2026-01-06 | Lizzul Paul F. Chief Medical Officer | Grant or award · Stock Option (right to buy) | +29,000 | 29,000 | ||
| 2026-01-06 | Jain Rita Director | Grant or award · Stock Option (right to buy) | +5,500 | 5,500 | ||
| 2026-01-06 | Jain Rita Director | Grant or award · Restricted Stock Unit | +4,000 | 4,000 | ||
| 2026-01-06 | Faga Daniel President, CEO | Option exercise | +17,850 | 475,989 | ||
| 2026-01-06 | Faga Daniel President, CEO | Option exercise · Restricted Stock Unit | −17,850 | 17,850 | ||
| 2026-01-06 | Faga Daniel President, CEO | Grant or award · Restricted Stock Unit | +98,600 | 98,600 | ||
| 2026-01-06 | Faga Daniel President, CEO | Grant or award · Stock Option (right to buy) | +133,400 | 133,400 | ||
| 2026-01-06 | Marquet Magda Director | Grant or award · Stock Option (right to buy) | +5,500 | 5,500 | ||
| 2026-01-06 | Marquet Magda Director | Grant or award · Restricted Stock Unit | +4,000 | 4,000 | ||
| 2026-01-06 | Schmid John P. Director | Grant or award · Stock Option (right to buy) | +5,500 | 5,500 | ||
| 2026-01-06 | Schmid John P. Director | Grant or award · Restricted Stock Unit | +4,000 | 4,000 | ||
| 2026-01-06 | Orwin John A Director | Grant or award · Stock Option (right to buy) | +8,250 | 8,250 | ||
| 2026-01-06 | Orwin John A Director | Grant or award · Restricted Stock Unit | +6,000 | 6,000 | ||
| 2026-01-06 | MULROY DENNIS CHIEF FINANCIAL OFFICER | Option exercise | +5,245 | 19,575 |
Page 7 of 17 · 339 trades